Xcout Intel
ImmunityBio competitors & alternatives
The 12 closest competitors and alternatives to ImmunityBio among biotech companies — ranked by similarity to what ImmunityBio actually does, not by market-cap band.
Subscribe to see ImmunityBio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ImmunityBio
ImmunityBio, Inc. is a public clinical-stage immunotherapy company headquartered in San Diego, California. As a member of the NantWorks ecosystem, it focuses on developing next-generation cancer vaccines and immunotherapies.
ImmunityBio at a glance
ImmunityBio is a biotech company headquartered in United States. It has raised at least $499.1M across the 3 funding rounds on record. Its most recent funding round, Growth, raised $470M in September 2023. Xcout tracks 11 named people at ImmunityBio, including Patrick Soon-Shiong (CEO). Xcout recorded 3 job postings from ImmunityBio in the last 90 days.
ImmunityBio leadership
- Patrick Soon-ShiongCEO
- Rich AdcockPresident & Chief Executive Officer
- David SachsChief Financial Officer
- Leonard S. Sender, M.D.Chief Medical Officer, Liquid Tumors & Cell Therapy
- Patrick Soon-Shiong, M.D.Executive Chairman and Global Chief Scientific and Medical Officer, ImmunityBio
- Dr. Jim Yong KimVice Chairman
5 more named people on record for ImmunityBio, with roles, board committees and tenure — see the full roster →
ImmunityBio funding rounds
At least $499.1M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Growth | $470M | 2 named | |
| SEC Form D filing | $10.7M | — | |
| Series B | $18.4M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at ImmunityBio
Xcout recorded 3 job postings from ImmunityBio in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see ImmunityBio's hiring signals →
Top 12 ImmunityBio competitors
Ranked by semantic similarity — how close each company is to ImmunityBio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
IO Biotech, Inc. is a clinical-stage biopharmaceutical company that develops novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines. Its proprietary T-win® technology is designed to modulate the tumor microenvironment by targeting both tumor cells and immune-suppressive cells, aiming to improve treatment outcomes for patients with melanoma and other tumor types.
Biotechnology
Imvax, Inc. is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing personalized, whole-cell immunotherapies for the treatment of various cancers.
Biotechnology
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Similar biotech company
ImmPACT Bio USA, Inc. is a clinical-stage biotechnology company headquartered in West Hills, California. The company focuses on developing advanced cell therapies and immunotherapies to treat cancer and other serious diseases.
Biotechnology
GlobeImmune, Inc. is a clinical-stage biopharmaceutical company headquartered in Louisville, Colorado, focused on developing therapeutic vaccines to treat cancer and infectious diseases.
Biotechnology
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Biotechnology
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Similar biotech company
Neuvogen is a privately held immunooncology company headquartered in San Diego, California, applying a systems approach to develop advanced therapies. The organization operates with a small team focused on cancer immunotherapy solutions.
Biotechnology
Immune Design Corp. is a clinical-stage immunotherapy company with offices in Seattle, Washington, and South San Francisco, California, specializing in novel drug discovery and treatment technologies.
Biotechnology
Agenus Inc. is a biotechnology company headquartered in Lexington, Massachusetts, focused on the discovery and development of better immunotherapies and cancer treatments.
Biotechnology
ME Therapeutics Holdings Inc. is a clinical-stage biotechnology company that discovers and develops immuno-oncology therapeutics designed to reprogram immune cells in vivo. Its pipeline aims to activate the body's immune system to recognize and fight cancer cells.
Biotechnology
ImmPACT Bio is a biotechnology company developing next-generation cancer immunotherapies, including dual-targeted CAR T-cell therapies. Its programs are intended to serve patients with B-cell malignancies and potentially other cancers, including solid tumors.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ImmunityBio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ImmunityBioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →